This week’s roundup is focused on the Life Science industry. Read on for articles from Qmed and Quality Digest experts as they cover topics on the medical device tax and a different approach to data structures. We conclude by looking into the importance of risk management and setting risk parameters.
Ding Dong the Device Tax is (Almost) Dead
Author: Amanda Pedersen via Qmed
In this article, author Amanda Pedersen states that the GOP Healthcare bill would permanently do away with the 2.3% medical device tax. She continues by saying that industry trade groups have been strongly pushing for a permanent repeal of the device tax for months. In this informative article, we see two sides to the potential permanent repeal and the resulting outcomes. For more information, read on here.
The Three-Way Chart
Author: Donald J. Wheeler via Quality Digest
This article shows users how some data structures need more than an average and range chart. The author provides insight into rational subgrouping, provides an overview of the three-way chart and how to use it, and more. For tips on creating useful charts, see the article here.
Risk Management and the Importance of Setting Risk Parameters
Author: Emily Ysaguirre via Verse Solutions Blog
Organizations in the U.S. Life Science industry must abide by rules and regulations set forth by the FDA. The FDA has placed significant oversight on adherence to specific requirements around compliance with regulations such as 21 CFR part 820 and part 11.
To effectively achieve compliance, organizations must have visibility into all adverse events and the risk these events pose on the organization. Risk Management tools provide the framework for handling these adverse events in a systematic way. Read more.